Bioequivalence Study of Montelukast, 5 mg Chewable Tablets (Pharmtechnology LLC, Belarus), and Singulair ®, 5 mg Chewable Tablets (Merck Sharp & Dohme B.V., the Netherlands), in Healthy Volunteers Under Fasting Conditions
Condition: Healthy Adults Interventions: Drug: Montelukast; Drug: Singulair Sponsors: Pharmtechnology LLC; ClinPharmInvest, LLC Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials